Pediatrix Medical (MD) Net Cash Flow (2009 - 2026)

Pediatrix Medical has disclosed Net Cash Flow across 18 years of filings, most recently posting -$169.5 million for Q1 2026.

• In Q1 2026, Net Cash Flow fell 30.75% year-over-year to -$169.5 million; the TTM figure through Mar 2026 stood at $105.4 million (up 2.37% YoY), while the FY2025 annual figure was $145.3 million, down 13.18% from the prior year.
• Net Cash Flow retreated to -$169.5 million in Q1 2026, from $35.2 million in the prior quarter.
• Over the last five years, Net Cash Flow for MD reached as high as $127.9 million in Q4 2024 and fell as low as -$372.7 million in Q1 2022.
• The 5-year median for Net Cash Flow is $3.3 million (2023), against an average of -$10.1 million.
• Annual changes were most pronounced in 2023 — Net Cash Flow soared 4405.1% — and 2024, when it sank 1804.29%.
• A 5-year view of Net Cash Flow shows it stood at $1.2 million in 2022, then soared by 4405.1% to $52.1 million in 2023, then surged by 145.6% to $127.9 million in 2024, then plunged by 72.49% to $35.2 million in 2025, then plunged by 581.67% to -$169.5 million in 2026.
• According to Business Quant data, Net Cash Flow over the past three periods registered -$169.5 million, $35.2 million, and $115.3 million for Q1 2026, Q4 2025, and Q3 2025 respectively.